Effective as of February 4, 2014, the board of directors of MetaStat, Inc. formally established a Scientific Advisory Board for Therapeutics, whose primary responsibilities include advising the company's management and the board on the long-term direction of the company's scientific and research goals as it relates to drug discovery and therapeutics. The members of the Scientific Advisory Board are David M. Epstein, Ph.D., Eric Winer, M.D., Michael T. Hemann, M.D., Ph.D., Mariano A. Garcia-Blanco, M.D., Ph.D., Adrian Krainer, Ph.D. and Frank B. Gertler, Ph.D. Dr. Epstein will serve as Chairman of the Scientific Advisory Board for Therapeutics. Dr. Epstein was appointed to MetaStat's board of directors and chair of drug discovery and development team effective as of April 16, 2013, and chairman of the scientific advisory board for therapeutics on February 4, 2014.

Dr. Epstein is currently Associate Professor in Cancer & Stem Cell Biology and Director of the Center for Technology and Development at Duke-NUS Medical School in Singapore.